Award notice Supplies
Fourniture de poches de nutrition parentérale et micronutriments
Notice published in French. The AI analysis summarises it for you in your language.
- Public buyer
- MercurHosp ASBL
Erpent - Place of performance
- 5101 Erpent
not published: buyer's address - Planned end of contract
- 1 August 2026
- Bids received
- 2
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 15 October 2024
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Marché pluriannuel de fourniture de poches de nutrition parentérales pour adultes et pédiatriques, ainsi que de micronutriments
Awarded to
7 lots
- MH-MT-112023-NUTRITION PARENTERALE - 1
- MH-MT-112023-NUTRITION PARENTERALE - 2
- MH-MT-112023-NUTRITION PARENTERALE - 3
- MH-MT-112023-NUTRITION PARENTERALE - 4
- MH-MT-112023-NUTRITION PARENTERALE - 5
- MH-MT-112023-NUTRITION PARENTERALE - 6
- MH-MT-112023-NUTRITION PARENTERALE - 7
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Fourniture d'azaticidine MercurHosp ASBL · 3 August 2026 |
Fresenius Kabi | €67,433 |
| Fourniture d'analogues de la somatostatine MercurHosp ASBL · 1 October 2025 |
Pharmanovia Benelux B.V. NOVARTIS PHARMA |
€606,086 |
| Générateurs de Technétium (99M Tc) et produits radiopharmaceutiques MercurHosp ASBL · 1 October 2025 |
GE HEALTHCARE CISBIO International Curium Belgium |
€12,256,476 |
| ATOSIBAN IV MercurHosp ASBL · 30 September 2025 |
FERRING | €391,336 |
| Meropenem injectable MercurHosp ASBL · 30 September 2025 |
Fresenius Kabi | €440,575 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 620578-2024.